{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:42:14Z","timestamp":1793727734465,"version":"4.6.1"},"reference-count":70,"publisher":"XMLink","issue":"3","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ejgo.org"],"crossmark-restriction":false},"short-container-title":["J Gynecol Oncol"],"DOI":"10.3802\/jgo.2026.37.e65","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:40:16Z","timestamp":1778722816000},"update-policy":"https:\/\/doi.org\/10.3802\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Trastuzumab deruxtecan in HER2-expressing gynecologic cancers from DESTINY-PanTumor02: antitumor activity, safety, and exploratory biomarker analyses"],"prefix":"10.3802","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7948-1350","authenticated-orcid":false,"given":"Jung-Yun","family":"Lee","sequence":"first","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3592-7194","authenticated-orcid":false,"given":"Ana","family":"Oaknin","sequence":"additional","affiliation":[{"name":"Medical Oncology Service, Vall d\u2019Hebron Institute of Oncology, Vall d\u2019Hebron Barcelona Hospital Campus, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1683-550X","authenticated-orcid":false,"given":"Luis","family":"Manso","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8376-9576","authenticated-orcid":false,"given":"Antonio","family":"Gonz\u00e1lez-Mart\u00edn","sequence":"additional","affiliation":[{"name":"Medical Oncology Department and Programme in Solid Tumours CIMA, Cancer Center Cl\u00ednica Universidad de Navarra, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9511-178X","authenticated-orcid":false,"given":"Iwona","family":"\u0141ugowska","sequence":"additional","affiliation":[{"name":"Center for Excellence in Precision Medicine, Maria Sk\u0142odowska-Curie National Research Institute of Oncology, Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0981-0598","authenticated-orcid":false,"given":"Domenica","family":"Lorusso","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy."},{"name":"Humanitas San Pio X, Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8840-7934","authenticated-orcid":false,"given":"Susana","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Gynaecology Unit, The Royal Marsden NHS Foundation Trust, London, UK."},{"name":"Institute of Cancer Research, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3018-7879","authenticated-orcid":false,"given":"John B.","family":"Liao","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, University of Washington, Seattle, WA, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7860-4320","authenticated-orcid":false,"given":"Chien-Hsing","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Taichung Veterans General Hospital, Taichung, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0634-2541","authenticated-orcid":false,"given":"Naiyarat","family":"Prasongsook","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Medicine, Phramongkutklao Hospital, Bangkok, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5474-6866","authenticated-orcid":false,"given":"Bohuslav","family":"Melichar","sequence":"additional","affiliation":[{"name":"Department of Oncology, Palacky University Medical School and University Hospital, Olomouc, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5389-7244","authenticated-orcid":false,"given":"Chiedozie","family":"Anoka","sequence":"additional","affiliation":[{"name":"Global Medicines Development, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1460-7463","authenticated-orcid":false,"given":"Lindsey","family":"Jung","sequence":"additional","affiliation":[{"name":"Oncology Biometrics, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3727-4887","authenticated-orcid":false,"given":"Flavia","family":"Michelini","sequence":"additional","affiliation":[{"name":"Translational Medicine, Oncology R&D, AstraZeneca, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9284-1824","authenticated-orcid":false,"given":"Soham","family":"Puvvada","sequence":"additional","affiliation":[{"name":"Clinical Development, Late Oncology, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6816-6072","authenticated-orcid":false,"given":"Funda","family":"Meric-Bernstam","sequence":"additional","affiliation":[{"name":"Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9793-7614","authenticated-orcid":false,"given":"Vicky","family":"Makker","sequence":"additional","affiliation":[{"name":"Gynecologic Medical Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA."},{"name":"Department of Medicine, Weill Cornell Medical College, New York, NY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18617","published-online":{"date-parts":[[2026]]},"reference":[{"key":"10.3802\/jgo.2026.37.e65_ref1","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/bjc.2017.422","volume":"118","author":"Halle","year":"2018","journal-title":"Br J Cancer"},{"key":"10.3802\/jgo.2026.37.e65_ref2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.annonc.2023.08.005","volume":"34","author":"Uzunparmak","year":"2023","journal-title":"Ann Oncol"},{"key":"10.3802\/jgo.2026.37.e65_ref3","doi-asserted-by":"crossref","first-page":"e0191972","DOI":"10.1371\/journal.pone.0191972","volume":"13","author":"Luo","year":"2018","journal-title":"PLoS One"},{"key":"10.3802\/jgo.2026.37.e65_ref4","first-page":"217","volume":"29","author":"Xu","year":"2025","journal-title":"Oncol Lett"},{"key":"10.3802\/jgo.2026.37.e65_ref5","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/JS9.0000000000000370","volume":"109","author":"Gao","year":"2023","journal-title":"Int J Surg"},{"key":"10.3802\/jgo.2026.37.e65_ref6","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1200\/JCO.2005.03.4827","volume":"24","author":"Morrison","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3802\/jgo.2026.37.e65_ref7","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1634\/theoncologist.2015-0149","volume":"20","author":"Diver","year":"2015","journal-title":"Oncologist"},{"key":"10.3802\/jgo.2026.37.e65_ref8","doi-asserted-by":"crossref","first-page":"112112","DOI":"10.1016\/j.intimp.2024.112112","volume":"133","author":"Chen","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.3802\/jgo.2026.37.e65_ref9","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.3390\/cancers12092678","volume":"12","author":"Gadducci","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.3802\/jgo.2026.37.e65_ref10","first-page":"229","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.3802\/jgo.2026.37.e65_ref11","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/modpathol.2013.113","volume":"26","author":"Buza","year":"2013","journal-title":"Mod Pathol"},{"key":"10.3802\/jgo.2026.37.e65_ref12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/his.14381","volume":"79","author":"Vermij","year":"2021","journal-title":"Histopathology"},{"key":"10.3802\/jgo.2026.37.e65_ref13","first-page":"55","volume":"39","author":"Semiz","year":"2023","journal-title":"Turk Patoloji Derg"},{"key":"10.3802\/jgo.2026.37.e65_ref14","first-page":"218","volume":"5","author":"Panek","year":"2007","journal-title":"Gin Onkol"},{"key":"10.3802\/jgo.2026.37.e65_ref15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/cjp2.184","volume":"7","author":"Shi","year":"2021","journal-title":"J Pathol Clin Res"},{"key":"10.3802\/jgo.2026.37.e65_ref16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/sj.bjc.6603581","volume":"96","author":"Pils","year":"2007","journal-title":"Br J Cancer"},{"key":"10.3802\/jgo.2026.37.e65_ref17","doi-asserted-by":"crossref","first-page":"e1138","DOI":"10.1371\/journal.pone.0001138","volume":"2","author":"Tuefferd","year":"2007","journal-title":"PLoS One"},{"key":"10.3802\/jgo.2026.37.e65_ref18","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.3802\/jgo.2019.30.e75","volume":"30","author":"Chung","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"10.3802\/jgo.2026.37.e65_ref19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/PGP.0000000000000812","volume":"41","author":"Ersoy","year":"2022","journal-title":"Int J Gynecol Pathol"},{"key":"10.3802\/jgo.2026.37.e65_ref20","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1158\/1078-0432.CCR-15-2822","volume":"22","author":"Ogitani","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.3802\/jgo.2026.37.e65_ref21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1248\/cpb.c18-00744","volume":"67","author":"Nakada","year":"2019","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.3802\/jgo.2026.37.e65_ref22","unstructured":"Daiichi Sankyo. Press release. ENHERTU\u00ae approved in Japan as first HER2 directed therapy for patients with HER2 low metastatic breast cancer [Internet]. Tokyo. Daiichi Sankyo. 2023. cited 2024 Apr 5. Available from: https:\/\/www.daiichisankyo.com\/files\/news\/pressrelease\/pdf\/202303\/20230327_E.pdf"},{"key":"10.3802\/jgo.2026.37.e65_ref23","unstructured":"European Medicines Agency (EMA). ENHERTU: summary of product characteristics (SmPC) [Internet]. Amsterdam. EMA. 2025. cited 2025 Sep 19. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/enhertu-epar-product-information_en.pdf"},{"key":"10.3802\/jgo.2026.37.e65_ref24","unstructured":"US Food and Drug Administration (FDA). ENHERTU (fam-trastuzumab deruxtecan-nxki): highlights of prescribing information (PI) [Internet]. Silver Spring, MD. US FDA. 2025. cited 2025 Sep 19. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/761139s032s035lbl.pdf"},{"key":"10.3802\/jgo.2026.37.e65_ref25","unstructured":"Electronic Medicines Compendium (EMC). ENHERTU: summary of product characteristics [Internet]. London. EMC. 2025. cited 2026 Apr 28. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/12135\/smpc"},{"key":"10.3802\/jgo.2026.37.e65_ref26","unstructured":"The Israeli Drug Registry. ENHERTU: summary of product characteristics [Internet]. Jerusalem. The Israeli Drug Registry. 2024. cited 2025 Aug 21. Available from: https:\/\/mohpublic.z6.web.core.windows.net\/IsraelDrugs\/Rishum01_23_180613625.pdf"},{"key":"10.3802\/jgo.2026.37.e65_ref27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1200\/JCO.23.02005","volume":"42","author":"Meric-Bernstam","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.3802\/jgo.2026.37.e65_ref28","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.5858\/arpa.2016-0331-CP","volume":"140","author":"Bartley","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.3802\/jgo.2026.37.e65_ref29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrc.2016.35","volume":"16","author":"Carr","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.3802\/jgo.2026.37.e65_ref30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13000-016-0545-8","volume":"11","author":"Rebelatto","year":"2016","journal-title":"Diagn Pathol"},{"key":"10.3802\/jgo.2026.37.e65_ref31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12885-021-09082-y","volume":"22","author":"Lai","year":"2022","journal-title":"BMC Cancer"},{"key":"10.3802\/jgo.2026.37.e65_ref32","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","volume":"399","author":"Crosbie","year":"2022","journal-title":"Lancet"},{"key":"10.3802\/jgo.2026.37.e65_ref33","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1056\/NEJMoa2108330","volume":"386","author":"Makker","year":"2022","journal-title":"N Engl J Med"},{"key":"10.3802\/jgo.2026.37.e65_ref34","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1200\/JCO.2013.51.4489","volume":"32","author":"Pujade-Lauraine","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.3802\/jgo.2026.37.e65_ref35","doi-asserted-by":"crossref","first-page":"S782","DOI":"10.1016\/j.annonc.2022.07.648","volume":"33","author":"Oaknin","year":"2022","journal-title":"Ann Oncol"},{"key":"10.3802\/jgo.2026.37.e65_ref36","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1158\/1078-0432.CCR-15-0887","volume":"21","author":"Kim","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.3802\/jgo.2026.37.e65_ref37","unstructured":"European Society for Medical Oncology (ESMO). EMA recommends extension of therapeutic indications for olaparib to patients with endometrial cancer [Internet]. Lugano. ESMO. 2024. cited 2025 May 2. Available from: https:\/\/www.esmo.org\/oncology-news\/ema-recommends-extension-of-therapeutic-indications-for-olaparib-to-patients-with-endometrial-cancer"},{"key":"10.3802\/jgo.2026.37.e65_ref38","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1056\/NEJMoa2216334","volume":"388","author":"Mirza","year":"2023","journal-title":"N Engl J Med"},{"key":"10.3802\/jgo.2026.37.e65_ref39","doi-asserted-by":"crossref","first-page":"104086","DOI":"10.1016\/j.critrevonc.2023.104086","volume":"190","author":"Fanale","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.3802\/jgo.2026.37.e65_ref40","doi-asserted-by":"crossref","first-page":"104203","DOI":"10.1016\/j.drudis.2024.104203","volume":"29","author":"Mun","year":"2024","journal-title":"Drug Discov Today"},{"key":"10.3802\/jgo.2026.37.e65_ref41","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1200\/JCO.22.02558","volume":"41","author":"Nishikawa","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.3802\/jgo.2026.37.e65_ref42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1158\/1078-0432.CCR-20-2488","volume":"27","author":"Sheng","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.3802\/jgo.2026.37.e65_ref43","first-page":"A6","volume":"34","author":"Wu","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"10.3802\/jgo.2026.37.e65_ref44","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1200\/JCO.2024.42.16_suppl.5528","volume":"42","author":"Yuan","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.3802\/jgo.2026.37.e65_ref45","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1200\/JCO.23.00606","volume":"41","author":"Nakamura","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.3802\/jgo.2026.37.e65_ref46","doi-asserted-by":"crossref","first-page":"TPS587","DOI":"10.1200\/JCO.2023.41.6_suppl.TPS587","volume":"41","author":"Yu","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.3802\/jgo.2026.37.e65_ref47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ygyno.2023.12.028","volume":"182","author":"Lumish","year":"2024","journal-title":"Gynecol Oncol"},{"key":"10.3802\/jgo.2026.37.e65_ref48","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1517\/13543784.2010.515585","volume":"19","author":"Matsuo","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"key":"10.3802\/jgo.2026.37.e65_ref49","doi-asserted-by":"crossref","first-page":"1114484","DOI":"10.3389\/fonc.2023.1114484","volume":"13","author":"Li","year":"2023","journal-title":"Front Oncol"},{"key":"10.3802\/jgo.2026.37.e65_ref50","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S1470-2045(24)00380-2","volume":"25","author":"Raghav","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.3802\/jgo.2026.37.e65_ref51","doi-asserted-by":"crossref","first-page":"e2400419","DOI":"10.1200\/PO-24-00419","volume":"8","author":"Holla","year":"2024","journal-title":"JCO Precis Oncol"},{"key":"10.3802\/jgo.2026.37.e65_ref52","first-page":"176","volume":"71","author":"Cheng","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.3802\/jgo.2026.37.e65_ref53","doi-asserted-by":"crossref","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.3802\/jgo.2026.37.e65_ref54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2203690","volume":"387","author":"Modi","year":"2022","journal-title":"N Engl J Med"},{"key":"10.3802\/jgo.2026.37.e65_ref55","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMoa2407086","volume":"391","author":"Bardia","year":"2024","journal-title":"N Engl J Med"},{"key":"10.3802\/jgo.2026.37.e65_ref56","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1038\/s41591-023-02478-2","volume":"29","author":"Mosele","year":"2023","journal-title":"Nat Med"},{"key":"10.3802\/jgo.2026.37.e65_ref57","doi-asserted-by":"crossref","first-page":"100553","DOI":"10.1016\/j.esmoop.2022.100553","volume":"7","author":"Rugo","year":"2022","journal-title":"ESMO Open"},{"key":"10.3802\/jgo.2026.37.e65_ref58","doi-asserted-by":"crossref","first-page":"102378","DOI":"10.1016\/j.ctrv.2022.102378","volume":"106","author":"Swain","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"10.3802\/jgo.2026.37.e65_ref59","doi-asserted-by":"crossref","first-page":"100554","DOI":"10.1016\/j.esmoop.2022.100554","volume":"7","author":"Powell","year":"2022","journal-title":"ESMO Open"},{"key":"10.3802\/jgo.2026.37.e65_ref60","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2559.2008.03028.x","volume":"52","author":"Hofmann","year":"2008","journal-title":"Histopathology"},{"key":"10.3802\/jgo.2026.37.e65_ref61","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3390\/jcm9040935","volume":"9","author":"Huemer","year":"2020","journal-title":"J Clin Med"},{"key":"10.3802\/jgo.2026.37.e65_ref62","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/modpathol.2017.171","volume":"31","author":"Pfitzner","year":"2018","journal-title":"Mod Pathol"},{"key":"10.3802\/jgo.2026.37.e65_ref63","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1186\/s12885-024-12980-6","volume":"24","author":"Xiong","year":"2024","journal-title":"BMC Cancer"},{"key":"10.3802\/jgo.2026.37.e65_ref64","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10549-013-2444-y","volume":"138","author":"Perez","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.3802\/jgo.2026.37.e65_ref65","author":"Badve","year":"2026","journal-title":"Virchows Arch"},{"key":"10.3802\/jgo.2026.37.e65_ref66","first-page":"704","volume":"18","author":"Goddard","year":"2012","journal-title":"Am J Manag Care"},{"key":"10.3802\/jgo.2026.37.e65_ref67","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.5858\/arpa.2022-0229-CP","volume":"147","author":"Hagemann","year":"2023","journal-title":"Arch Pathol Lab Med"},{"key":"10.3802\/jgo.2026.37.e65_ref68","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1007\/s12325-024-02975-x","volume":"41","author":"Oaknin","year":"2024","journal-title":"Adv Ther"},{"key":"10.3802\/jgo.2026.37.e65_ref69","unstructured":"AstraZeneca. NCT06989112. DESTINY-Endometrial01: a phase III study of trastuzumab deruxtecan plus rilvegostomig or pembrolizumab as first-line treatment of HER2-expressing (IHC 3+\/2+), mismatch repair proficient (pMMR) endometrial cancer (DE-01) [Internet]. Bethesda, MD. National Library of Medicine. 2025. cited 2025 Jun 16. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06989112"},{"key":"10.3802\/jgo.2026.37.e65_ref70","unstructured":"Daiichi Sankyo. NCT06819007. Study of trastuzumab deruxtecan with bevacizumab versus bevacizumab monotherapy for first-line maintenance in HER2-expressing ovarian cancer (DESTINY-Ovarian01) [Internet]. Bethesda, MD. National Library of Medicine. 2025. cited 2025 Jun 16. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06819007"}],"container-title":["Journal of Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ejgo.org\/pdf\/10.3802\/jgo.2026.37.e65","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ejgo.org\/DOIx.php?id=10.3802\/jgo.2026.37.e65","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ejgo.org\/DOIx.php?id=10.3802\/jgo.2026.37.e65","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:16:46Z","timestamp":1779841006000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejgo.org\/DOIx.php?id=10.3802\/jgo.2026.37.e65"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":70,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3802\/jgo.2026.37.e65","relation":{},"ISSN":["2005-0380","2005-0399"],"issn-type":[{"value":"2005-0380","type":"print"},{"value":"2005-0399","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2026-01-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-02","name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-06","name":"published_online","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"\u00a9 2026. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology, and Japan Society of Gynecologic Oncology","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","explanation":{"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},"group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}],"article-number":"e65"}}